Notice
[Filing] New Facilities Investment
Writer : Alteogen
Date : 2026.08.21
| 1. Type of Investment | Decision to invest in the construction of a new biologics manufacturing plant | |
| 2. Details of Investment. etc. | Investment Amount (KRW) | 253,200,000,000 |
| Equity Capital(KRW) | 454,442,940,148 | |
| Ratio to Equity Capital(%) | 55.7 | |
| Applicability of Large-scale Corporation | No | |
| 3. Purpose of Investment | To secure production capacity to support the expansion of the biopharmaceutical business and meet growing demand in global markets | |
| 4. Investment Period | From | 2026-08-21 |
| To | 2028-09-30 | |
| 5. Date of Board of Directors' Resolution(Decision Date) | 2026-08-21 | |
| -Attendance of Outside Directors | Present(No.) | 4 |
| Absent(No.) | - | |
| 6. Attendance of Auditors(members of Audit Committee) | Present | |
| 7. Contents of Non-Disclosure | Reason For Non-Disclosure | - |
| Period of Non-Disclosure | - | |
| 8. Other references concerning investment decisions | - The investment amount under “2. Details of Investment” includes the costs for building construction, facilities, and machinery and equipment. - The equity capital under “2. Details of Investment” is based on the 2025 consolidated financial statements. - The investment amount under “2. Details of Investment” is scheduled to be invested over a three-year period through 2028. However, the amount may change depending on changes in the business environment during the execution process. - The end date under “4. Investment Period” is the expected date of completion of the plant construction and may change depending on changes in the business environment, such as construction permits, construction progress, and the Company's schedule. - The new plant will be located in Dungok District, Daejeon Metropolitan City. | |